These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 34846678)
1. In Vivo Evaluation of Near-Infrared Fluorescent Probe for TIM3 Targeting in Mouse Glioma. Zhang M; Zhou Q; Huang C; Chan CT; Wu W; Li G; Lim M; Gambhir SS; Daldrup-Link HE Mol Imaging Biol; 2022 Apr; 24(2):280-287. PubMed ID: 34846678 [TBL] [Abstract][Full Text] [Related]
2. Construction and Preclinical Evaluation of Tao J; Zeng Z; He C; Meng L; Zhou W; Ren Y; Ma X; Wang Z; Liu J; Li D; Zhang Q; Zhao C; Yang Z; Zhu H Mol Pharm; 2024 Feb; 21(2):944-956. PubMed ID: 38270082 [TBL] [Abstract][Full Text] [Related]
3. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW. Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144 [TBL] [Abstract][Full Text] [Related]
4. In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis. Yang Y; Zhang Y; Hong H; Liu G; Leigh BR; Cai W Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):2066-76. PubMed ID: 21814852 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model. Soltantoyeh T; Akbari B; Shahosseini Z; Mirzaei HR; Hadjati J Front Immunol; 2024; 15():1362904. PubMed ID: 38855110 [TBL] [Abstract][Full Text] [Related]
8. Combination therapy with anti-T-cell immunoglobulin and mucin-domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma. Kim KJ; Lee HW; Seong J J Gastroenterol Hepatol; 2021 May; 36(5):1357-1365. PubMed ID: 33217056 [TBL] [Abstract][Full Text] [Related]
9. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905 [TBL] [Abstract][Full Text] [Related]
10. Combined Blockade of T Cell Immunoglobulin and Mucin Domain 3 and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Results in Durable Therapeutic Efficacy in Mice with Intracranial Gliomas. Li J; Liu X; Duan Y; Liu Y; Wang H; Lian S; Zhuang G; Fan Y Med Sci Monit; 2017 Jul; 23():3593-3602. PubMed ID: 28736431 [TBL] [Abstract][Full Text] [Related]
11. Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer. Liu JF; Wu L; Yang LL; Deng WW; Mao L; Wu H; Zhang WF; Sun ZJ J Exp Clin Cancer Res; 2018 Mar; 37(1):44. PubMed ID: 29506555 [TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9-Mediated TIM3 Knockout in Human Natural Killer Cells Enhances Growth Inhibitory Effects on Human Glioma Cells. Morimoto T; Nakazawa T; Matsuda R; Nishimura F; Nakamura M; Yamada S; Nakagawa I; Park YS; Tsujimura T; Nakase H Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800561 [TBL] [Abstract][Full Text] [Related]
18. [Effect of Shi Y; Abidan A; Li D; Zibigu R; Wang M; Zheng X; Kang X; Wang H; Li J; Zhang C Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Sep; 35(4):366-373. PubMed ID: 37926471 [TBL] [Abstract][Full Text] [Related]
19. IL8 derived from macrophages inhibits CD8 Zhao C; Wang D; Li Z; Zhang Z; Xu Y; Liu J; Lei Q; Han D; Huo Y; Liu S; Li L; Zhang Y Int Immunopharmacol; 2023 Aug; 121():110457. PubMed ID: 37331296 [TBL] [Abstract][Full Text] [Related]